---
layout: default
title: Evaluating New AI Cell Foundation Models on Challenging Kidney Pathology Cases Unaddressed by Previous Foundation Models
---

# Evaluating New AI Cell Foundation Models on Challenging Kidney Pathology Cases Unaddressed by Previous Foundation Models

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2510.01287" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2510.01287v1</a>
  <a href="https://arxiv.org/pdf/2510.01287.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2510.01287v1" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2510.01287v1', 'Evaluating New AI Cell Foundation Models on Challenging Kidney Pathology Cases Unaddressed by Previous Foundation Models')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Runchen Wang, Junlin Guo, Siqi Lu, Ruining Deng, Zhengyi Lu, Yanfan Zhu, Yuechen Yang, Chongyu Qu, Yu Wang, Shilin Zhao, Catie Chang, Mitchell Wilkes, Mengmeng Yin, Haichun Yang, Yuankai Huo

**åˆ†ç±»**: q-bio.QM, cs.AI

**å‘å¸ƒæ—¥æœŸ**: 2025-10-01

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**è¯„ä¼°æ–°å‹AIç»†èƒåˆ†å‰²æ¨¡å‹åœ¨è‚¾è„ç—…ç†ç–‘éš¾æ¡ˆä¾‹ä¸­çš„æ€§èƒ½ï¼Œè§£å†³å…ˆå‰æ¨¡å‹æœªè§£å†³çš„é—®é¢˜ã€‚**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±ä¹ï¼šå…·èº«å¤§æ¨¡å‹ (Embodied Foundation Models)**

**å…³é”®è¯**: `ç»†èƒåˆ†å‰²` `è‚¾è„ç—…ç†` `AIåŸºç¡€æ¨¡å‹` `æ¨¡å‹èåˆ` `æ·±åº¦å­¦ä¹ ` `åŒ»å­¦å›¾åƒåˆ†æ` `CellViT++`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. è‚¾è„ç—…ç†å›¾åƒä¸­ç»†èƒæ ¸åˆ†å‰²é¢ä¸´å½¢æ€å¤šæ ·æ€§å’Œæˆåƒå·®å¼‚çš„æŒ‘æˆ˜ï¼Œç°æœ‰æ–¹æ³•éš¾ä»¥æœ‰æ•ˆå¤„ç†ã€‚
2. è®ºæ–‡è¯„ä¼°äº†æœ€æ–°çš„AIç»†èƒåˆ†å‰²åŸºç¡€æ¨¡å‹ï¼Œå¹¶æå‡ºèåˆç­–ç•¥ä»¥æå‡ç–‘éš¾æ¡ˆä¾‹çš„åˆ†å‰²ç²¾åº¦ã€‚
3. å®éªŒè¡¨æ˜ï¼ŒCellViT++æ¨¡å‹è¡¨ç°æœ€ä½³ï¼Œèåˆæ¨¡å‹æ˜¾è‘—æå‡åˆ†å‰²è´¨é‡ï¼Œå°¤å…¶åœ¨ç–‘éš¾æ¡ˆä¾‹ä¸Šã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

ç²¾ç¡®çš„ç»†èƒæ ¸åˆ†å‰²å¯¹äºè‚¾è„ç—…ç†å­¦ä¸­çš„ä¸‹æ¸¸ä»»åŠ¡è‡³å…³é‡è¦ï¼Œä½†ç”±äºè‚¾è„ç»„ç»‡å½¢æ€çš„å¤šæ ·æ€§å’Œæˆåƒçš„å¯å˜æ€§ï¼Œä»ç„¶æ˜¯ä¸€ä¸ªä¸»è¦çš„æŒ‘æˆ˜ã€‚è™½ç„¶æˆ‘ä»¬ä¹‹å‰çš„å·¥ä½œå·²ç»è¯„ä¼°äº†æ—©æœŸAIç»†èƒåŸºç¡€æ¨¡å‹åœ¨è¯¥é¢†åŸŸçš„æ€§èƒ½ï¼Œä½†æœ€è¿‘çš„ç»†èƒåŸºç¡€æ¨¡å‹çš„æœ‰æ•ˆæ€§ä»ä¸æ¸…æ¥šã€‚åœ¨æœ¬ç ”ç©¶ä¸­ï¼Œæˆ‘ä»¬ä½¿ç”¨åŒ…å«å¤§é‡è‚¾è„å›¾åƒå—çš„å¤šæ ·åŒ–æ•°æ®é›†ï¼Œåœ¨ä¸€ä¸ªäººå·¥å‚ä¸çš„è¯„ä¼°æ¡†æ¶ä¸­ï¼Œå¯¹åŒ…æ‹¬CellViT++å˜ä½“å’ŒCellpose-SAMåœ¨å†…çš„å…ˆè¿›AIç»†èƒåŸºç¡€æ¨¡å‹ï¼ˆ2025ï¼‰ä¸2024å¹´ä¹‹å‰å¼€å‘çš„ä¸‰ç§å¹¿æ³›ä½¿ç”¨çš„ç»†èƒåŸºç¡€æ¨¡å‹è¿›è¡Œäº†åŸºå‡†æµ‹è¯•ã€‚æˆ‘ä»¬è¿›ä¸€æ­¥è¿›è¡Œäº†åŸºäºèåˆçš„é›†æˆè¯„ä¼°å’Œæ¨¡å‹ä¸€è‡´æ€§åˆ†æï¼Œä»¥è¯„ä¼°ä¸åŒæ¨¡å‹çš„åˆ†å‰²èƒ½åŠ›ã€‚ç»“æœè¡¨æ˜ï¼ŒCellViT++ [Virchow] äº§ç”Ÿäº†æœ€é«˜çš„ç‹¬ç«‹æ€§èƒ½ï¼Œåœ¨ç²¾å¿ƒç­–åˆ’çš„2,091ä¸ªå…·æœ‰æŒ‘æˆ˜æ€§çš„æ ·æœ¬é›†ä¸­ï¼Œæœ‰40.3%çš„é¢„æµ‹è¢«è¯„ä¸ºâ€œè‰¯å¥½â€ï¼Œä¼˜äºæ‰€æœ‰å…ˆå‰çš„æ¨¡å‹ã€‚æ­¤å¤–ï¼Œæˆ‘ä»¬çš„èåˆæ¨¡å‹å®ç°äº†62.2%çš„â€œè‰¯å¥½â€é¢„æµ‹å’Œä»…0.4%çš„â€œå·®â€é¢„æµ‹ï¼Œå¤§å¤§å‡å°‘äº†åˆ†å‰²é”™è¯¯ã€‚å€¼å¾—æ³¨æ„çš„æ˜¯ï¼Œèåˆæ¨¡å‹ï¼ˆ2025ï¼‰æˆåŠŸè§£å†³äº†æˆ‘ä»¬ä¹‹å‰ç ”ç©¶ä¸­æœªè§£å†³çš„å¤§éƒ¨åˆ†å…·æœ‰æŒ‘æˆ˜æ€§çš„æ¡ˆä¾‹ã€‚è¿™äº›å‘ç°è¯æ˜äº†AIç»†èƒåŸºç¡€æ¨¡å‹åœ¨è‚¾è„ç—…ç†å­¦ä¸­å¼€å‘çš„æ½œåŠ›ï¼Œå¹¶æä¾›äº†ä¸€ä¸ªå…·æœ‰æŒ‘æˆ˜æ€§çš„æ ·æœ¬çš„ç²¾é€‰æ•°æ®é›†ï¼Œä»¥æ”¯æŒæœªæ¥ç‰¹å®šäºè‚¾è„çš„æ¨¡å‹æ”¹è¿›ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šè®ºæ–‡æ—¨åœ¨è§£å†³è‚¾è„ç—…ç†å›¾åƒä¸­ç»†èƒæ ¸åˆ†å‰²çš„éš¾é¢˜ï¼Œç‰¹åˆ«æ˜¯ç°æœ‰AIç»†èƒåˆ†å‰²æ¨¡å‹åœ¨å¤„ç†å½¢æ€å¤šæ ·ã€æˆåƒå·®å¼‚å¤§çš„è‚¾è„ç»„ç»‡æ—¶ï¼Œåˆ†å‰²ç²¾åº¦ä¸è¶³çš„é—®é¢˜ã€‚ç°æœ‰æ–¹æ³•çš„ç—›ç‚¹åœ¨äºå¯¹å¤æ‚ç—…ç†å›¾åƒçš„æ³›åŒ–èƒ½åŠ›è¾ƒå¼±ï¼Œå®¹æ˜“å‡ºç°åˆ†å‰²é”™è¯¯ï¼Œå½±å“ä¸‹æ¸¸ç—…ç†åˆ†æçš„å‡†ç¡®æ€§ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šè®ºæ–‡çš„æ ¸å¿ƒè§£å†³æ€è·¯æ˜¯è¯„ä¼°å’Œèåˆæœ€æ–°çš„AIç»†èƒåˆ†å‰²åŸºç¡€æ¨¡å‹ï¼Œåˆ©ç”¨ä¸åŒæ¨¡å‹çš„ä¼˜åŠ¿äº’è¡¥ï¼Œä»è€Œæé«˜å¯¹å¤æ‚è‚¾è„ç—…ç†å›¾åƒçš„åˆ†å‰²ç²¾åº¦å’Œé²æ£’æ€§ã€‚é€šè¿‡äººå·¥è¯„ä¼°å’Œæ¨¡å‹ä¸€è‡´æ€§åˆ†æï¼Œç­›é€‰å‡ºè¡¨ç°ä¼˜å¼‚çš„æ¨¡å‹ï¼Œå¹¶é‡‡ç”¨èåˆç­–ç•¥è¿›ä¸€æ­¥æå‡æ€§èƒ½ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šæ•´ä½“æ¡†æ¶åŒ…æ‹¬æ•°æ®æ”¶é›†ä¸é¢„å¤„ç†ã€æ¨¡å‹é€‰æ‹©ä¸è®­ç»ƒã€äººå·¥è¯„ä¼°ä¸æ¨¡å‹èåˆã€ä»¥åŠç»“æœåˆ†æä¸éªŒè¯ã€‚ä¸»è¦æ¨¡å—åŒ…æ‹¬ï¼š1) åŸºäºå¤§è§„æ¨¡è‚¾è„ç—…ç†å›¾åƒæ•°æ®é›†è®­ç»ƒçš„å¤šä¸ªAIç»†èƒåˆ†å‰²æ¨¡å‹ï¼›2) äººå·¥å‚ä¸çš„è¯„ä¼°æ¡†æ¶ï¼Œç”¨äºå¯¹æ¨¡å‹é¢„æµ‹ç»“æœè¿›è¡Œè´¨é‡è¯„ä¼°ï¼›3) åŸºäºæ¨¡å‹é¢„æµ‹ç»“æœçš„èåˆç­–ç•¥ï¼Œæ—¨åœ¨ç»“åˆä¸åŒæ¨¡å‹çš„ä¼˜åŠ¿ï¼›4) æ¨¡å‹ä¸€è‡´æ€§åˆ†æï¼Œç”¨äºè¯„ä¼°ä¸åŒæ¨¡å‹ä¹‹é—´çš„é¢„æµ‹ä¸€è‡´æ€§ã€‚

**å…³é”®åˆ›æ–°**ï¼šè®ºæ–‡çš„å…³é”®åˆ›æ–°åœ¨äºï¼š1) ç³»ç»Ÿæ€§åœ°è¯„ä¼°äº†æœ€æ–°çš„AIç»†èƒåˆ†å‰²åŸºç¡€æ¨¡å‹åœ¨è‚¾è„ç—…ç†å›¾åƒåˆ†å‰²ä¸­çš„æ€§èƒ½ï¼›2) æå‡ºäº†åŸºäºèåˆçš„é›†æˆç­–ç•¥ï¼Œæœ‰æ•ˆæå‡äº†åˆ†å‰²ç²¾åº¦ï¼Œå°¤å…¶æ˜¯åœ¨ç–‘éš¾æ¡ˆä¾‹ä¸Šï¼›3) æ„å»ºäº†ä¸€ä¸ªåŒ…å«å¤§é‡å…·æœ‰æŒ‘æˆ˜æ€§çš„è‚¾è„ç—…ç†å›¾åƒçš„ç²¾é€‰æ•°æ®é›†ï¼Œä¸ºæœªæ¥æ¨¡å‹æ”¹è¿›æä¾›äº†åŸºç¡€ã€‚

**å…³é”®è®¾è®¡**ï¼šè®ºæ–‡çš„å…³é”®è®¾è®¡åŒ…æ‹¬ï¼š1) é€‰æ‹©äº†CellViT++å’ŒCellpose-SAMç­‰å…ˆè¿›çš„AIç»†èƒåˆ†å‰²æ¨¡å‹ï¼›2) é‡‡ç”¨äº†äººå·¥å‚ä¸çš„è¯„ä¼°æ¡†æ¶ï¼Œç¡®ä¿è¯„ä¼°ç»“æœçš„å¯é æ€§ï¼›3) è®¾è®¡äº†åŸºäºæ¨¡å‹é¢„æµ‹ç»“æœçš„èåˆç­–ç•¥ï¼Œä¾‹å¦‚åŠ æƒå¹³å‡æˆ–æŠ•ç¥¨æœºåˆ¶ï¼Œä»¥ç»“åˆä¸åŒæ¨¡å‹çš„ä¼˜åŠ¿ï¼›4) é’ˆå¯¹è‚¾è„ç—…ç†å›¾åƒçš„ç‰¹ç‚¹ï¼Œå¯èƒ½é‡‡ç”¨äº†ç‰¹å®šçš„æ•°æ®å¢å¼ºæ–¹æ³•æˆ–æŸå¤±å‡½æ•°ï¼Œä»¥æé«˜æ¨¡å‹çš„æ³›åŒ–èƒ½åŠ›ï¼ˆå…·ä½“ç»†èŠ‚æœªçŸ¥ï¼‰ã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

å®éªŒç»“æœè¡¨æ˜ï¼ŒCellViT++ [Virchow] åœ¨ç‹¬ç«‹æµ‹è¯•ä¸­è¡¨ç°æœ€ä½³ï¼Œåœ¨å…·æœ‰æŒ‘æˆ˜æ€§çš„æ ·æœ¬é›†ä¸­è¾¾åˆ°äº†40.3%çš„â€œè‰¯å¥½â€é¢„æµ‹ç‡ï¼Œä¼˜äºæ‰€æœ‰å…ˆå‰çš„æ¨¡å‹ã€‚æ›´é‡è¦çš„æ˜¯ï¼Œèåˆæ¨¡å‹å®ç°äº†62.2%çš„â€œè‰¯å¥½â€é¢„æµ‹å’Œä»…0.4%çš„â€œå·®â€é¢„æµ‹ï¼Œæ˜¾è‘—å‡å°‘äº†åˆ†å‰²é”™è¯¯ï¼Œå¹¶æˆåŠŸè§£å†³äº†ä¹‹å‰ç ”ç©¶ä¸­æœªè§£å†³çš„å¤§éƒ¨åˆ†ç–‘éš¾æ¡ˆä¾‹ã€‚è¿™è¡¨æ˜èåˆç­–ç•¥èƒ½å¤Ÿæœ‰æ•ˆæå‡è‚¾è„ç—…ç†å›¾åƒåˆ†å‰²çš„ç²¾åº¦å’Œé²æ£’æ€§ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶æˆæœå¯åº”ç”¨äºè‚¾è„ç–¾ç—…çš„è¾…åŠ©è¯Šæ–­ã€ç—…ç†åˆ†æå’Œè¯ç‰©ç ”å‘ç­‰é¢†åŸŸã€‚é€šè¿‡æé«˜ç»†èƒæ ¸åˆ†å‰²çš„å‡†ç¡®æ€§ï¼Œå¯ä»¥å¸®åŠ©ç—…ç†å­¦å®¶æ›´å‡†ç¡®åœ°è¯„ä¼°è‚¾è„ç»„ç»‡çš„ç—…å˜ç¨‹åº¦ï¼Œä»è€Œä¸ºæ‚£è€…æä¾›æ›´ç²¾å‡†çš„æ²»ç–—æ–¹æ¡ˆã€‚æ­¤å¤–ï¼Œè¯¥ç ”ç©¶æ„å»ºçš„ç²¾é€‰æ•°æ®é›†å¯ç”¨äºè®­ç»ƒå’Œè¯„ä¼°æ–°çš„è‚¾è„ç—…ç†å›¾åƒåˆ†å‰²æ¨¡å‹ï¼Œæ¨åŠ¨ç›¸å…³é¢†åŸŸçš„å‘å±•ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Accurate cell nuclei segmentation is critical for downstream tasks in kidney pathology and remains a major challenge due to the morphological diversity and imaging variability of renal tissues. While our prior work has evaluated early-generation AI cell foundation models in this domain, the effectiveness of recent cell foundation models remains unclear. In this study, we benchmark advanced AI cell foundation models (2025), including CellViT++ variants and Cellpose-SAM, against three widely used cell foundation models developed prior to 2024, using a diverse large-scale set of kidney image patches within a human-in-the-loop rating framework. We further performed fusion-based ensemble evaluation and model agreement analysis to assess the segmentation capabilities of the different models. Our results show that CellViT++ [Virchow] yields the highest standalone performance with 40.3% of predictions rated as "Good" on a curated set of 2,091 challenging samples, outperforming all prior models. In addition, our fused model achieves 62.2% "Good" predictions and only 0.4% "Bad", substantially reducing segmentation errors. Notably, the fusion model (2025) successfully resolved the majority of challenging cases that remained unaddressed in our previous study. These findings demonstrate the potential of AI cell foundation model development in renal pathology and provide a curated dataset of challenging samples to support future kidney-specific model refinement.

